Keros to Repurchase 11 Million Shares in Oversubscribed Tender Offer

MT Newswires Live
2025/11/19

Keros Therapeutics (KROS) said Wednesday that it will repurchase almost 11 million shares at $17.75 each, or a total of $194.4 million, in a tender offer that expired on Tuesday.

The offer was oversubscribed, with about 16.7 million shares validly tendered and about 1.2 million shares tendered through notice of guaranteed delivery, the company said.

The shares to be acquired represent around 35.91% of the company's outstanding stock as of Tuesday, Keros said

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10